Anton Syndrome Clinical Trials

Find Anton Syndrome Clinical Trials Near You

ICVP - A Phase I Clinical Trial to Determine the Feasibility of a Human Cortical Visual Prosthesis for People With Blindness

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The purpose of this study is to determine the feasibility of producing artificial vision in persons with blindness. Study participants will have wireless electrical stimulators implanted into the cortical vision processing areas of their brains. The ability of the participants to perceive artificial vision in response to electrical stimulation will be assessed.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 19
Maximum Age: 70
Healthy Volunteers: f
View:

• No light perception or bare light perception, in each eye in accordance with relevant International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) codes, where the physician has no expectation of improvement through currently approved treatments.

• History of normal or near-normal vision, with or without refractive correction, during at least the first 10 years of life.

• Adjusted to blindness for at least one year.

• History of vision or blindness rehabilitation.

• Willing and able to meet the time demands of the study with transportation assistance.

• Willing to agree to audio and video recording, as specified in the pre-screening consent.

• Motivated by altruism, willingness to participate in pioneering science.

• Demonstrated support from spouse, family and/or friends.

• High or average cognitive and spatial functioning.

• Normal structural MRI.

• English as preferred language.

• Normal decision-making capacity.

Locations
United States
Illinois
Illinois Tech
RECRUITING
Chicago
Contact Information
Primary
Recruitment Director
ICVP@illinoistech.edu
312-567-5304
Time Frame
Start Date: 2020-08-20
Estimated Completion Date: 2027-06-30
Participants
Target number of participants: 5
Treatments
Experimental: WFMA Cortical Visual Prosthesis Single-arm Study
The WFMA is an electronic device that is implanted in the cortical vision processing regions of the brain to produce artificial vision.
Related Therapeutic Areas
Sponsors
Leads: Illinois Institute of Technology
Collaborators: The University of Texas at Dallas, Johns Hopkins University, The Chicago Lighthouse, University of Chicago, Rush University Medical Center, National Institute of Neurological Disorders and Stroke (NINDS)

This content was sourced from clinicaltrials.gov

Similar Clinical Trials